Table 1.
Prostate Cancer | P 2 | ||||
Cases (n=1803) | Controls (n=1797) | ||||
|
|||||
Race | n | % | n | % | |
|
|||||
White | 1674 | 92.8 | 1426 | 79.4 | |
Black | 82 | 4.5 | 174 | 9.7 | |
Other | 47 | 2.6 | 197 | 11.0 | |
|
|||||
LS Mean | 95%CI | LS Mean | 95%CI | ||
|
|||||
Age (years) | 63.6 | 63.3-63.8 | 63.7 | 63.4-63.9 | 0.58 |
Body Mass Index [wt(kg)/ht(m)2] | 27.5 | 27.3-27.7 | 27.6 | 27.4-27.8 | 0.42 |
Waist circumference (cm) | 101.8 | 101.3-102.3 | 102.3 | 101.8-102.8 | 0.16 |
Waist:Hip ratio | 0.96 | 0.95-0.96 | 0.96 | 0.96-0.96 | 0.70 |
Smoking (pack-years) | 14.0 | 13.2-14.8 | 15.3 | 14.6-16.1 | 0.02 |
Alcohol intake (g/day) | 9.7 | 9.0-10.4 | 9.2 | 8.5-9.9 | 0.28 |
|
|||||
n | % (adjusted) 1 | n | %(adjusted) 1 | ||
|
|||||
Intervention arm3 | 761 | 43.0 | 763 | 41.7 | 0.42 |
Diabetes or insulin use | 84 | 5.3 | 133 | 6.8 | 0.05 |
Family history of prostate cancer |
384 | 20.8 | 382 | 21.8 | 0.48 |
Body Mass Index [wt(kg)/ht(m)2] | |||||
Normal (< 25.0) | 498 | 27.7 | 447 | 25.3 | 0.11 |
Overweight (25.0-29.9) | 913 | 50.8 | 941 | 53.2 | 0.15 |
Obese (≥ 30.0) | 376 | 21.3 | 391 | 21.3 | 0.99 |
Physical activity | |||||
Sedentary | 309 | 17.6 | 313 | 17.1 | 0.68 |
Light activity | 746 | 41.3 | 738 | 41.5 | 0.91 |
Moderate activity | 592 | 32.9 | 550 | 30.8 | 0.20 |
Very active | 149 | 8.2 | 188 | 10.6 | 0.02 |
Smoking status | |||||
Never smoker | 644 | 35.4 | 615 | 34.6 | 0.62 |
Current smoker | 122 | 7.1 | 138 | 7.3 | 0.87 |
Past smoker | 1037 | 57.5 | 1044 | 58.1 | 0.69 |
Education | |||||
High school or less | 308 | 17.6 | 348 | 18.9 | 0.32 |
Some college/college degree | 490 | 27.7 | 542 | 29.7 | 0.20 |
Graduate/professional school | 1004 | 54.7 | 906 | 51.4 | 0.05 |
Least squares means and adjusted percents are adjusted for race (white vs. non-white) due to the inclusion of all non-whites in the control group (see methods section for details).
p values are adjusted for race using linear regression to calculate least squaresd means, adjusted percents and p-values (see methods section for details).
Intervention arm participants were randomized to finasteride.